World Congress of Pediatric Dermatology (WCPD 2025) Session Highlights

• The IEC’s global expansion now includes 33 countries, aiming for increased representation and involvement from South America.

• Preclinical atopic dermatitis introduces a new paradigm for early interventions before visible symptoms emerge.

• Early introduction of allergenic foods during breastfeeding can significantly affect food allergy development in children with AD.

• Recognizing unique presentations of AD in children within diverse ethnic backgrounds necessitates bespoke treatment strategies.

• Recent developments in topical therapies like JAK inhibitors show promising results for patients aged 12 and older.

• The psychosocial impacts of AD highlight the importance of patient education and emotional support in treatment paradigms.

• A collaborative model of care that integrates dermatological, psychological, and educational support is essential to effective management.

American Academy of Dermatology (AAD) 2025 Global Education Day Session Highlights

• International Eczema Council Celebrates 10 Years - A global initiative promoting education and treatment for atopic dermatitis.
• Dr. Emma Guttman on Alopecia Areata Links - Emphasizes the connection between atopic dermatitis and alopecia areata, alongside future treatment research.
• Epidemiology Insights by Dr. Benjamin Ungar - Discusses alopecia areata’s prevalence and its association with other atopic conditions.
• Emerging Therapeutics - Itinib and delgocitinib highlighted as promising new treatments for atopic dermatitis and alopecia areata.
• Microbiome’s Role - New insights suggest that the microbiome significantly influences treatment outcomes for atopic dermatitis.
• Pediatric Focus - Highlights the influence of alopecia areata on children’s self-esteem and the psychosocial aspects affecting young patients.
• Innovative Treatments - Introduction of JAK inhibitors and novel agents targeting IL-4 and IL-13 pathways showing promise for dual diagnoses.

Key Insights